MSEGX
Price
$49.27
Change
-$0.00 (-0.00%)
Updated
May 7 closing price
Net Assets
3.77B
RGACX
Price
$70.16
Change
+$0.52 (+0.75%)
Updated
May 8 closing price
Net Assets
283.8B
Ad is loading...

MSEGX vs RGACX

Header iconMSEGX vs RGACX Comparison
Open Charts MSEGX vs RGACXBanner chart's image
Morgan Stanley Inst Growth A
Price$49.27
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets3.77B
American Funds Growth Fund of Amer R3
Price$70.16
Change+$0.52 (+0.75%)
VolumeN/A
Net Assets283.8B
MSEGX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSEGX vs. RGACX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSEGX is a Buy and RGACX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 284B vs. MSEGX (3.77B). MSEGX pays higher dividends than RGACX: MSEGX (0.43) vs RGACX (0.08). MSEGX was incepted earlier than RGACX: MSEGX (29 years) vs RGACX (23 years). RGACX (0.94) is less costly to investors than MSEGX (0.82). MSEGX is a more actively managed with annual turnover of: 39.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than MSEGX: RGACX (250) vs MSEGX (1000). MSEGX annual gain was more profitable for investors over the last year : 41.82 vs. RGACX (3.09). RGACX return over 5 years is better than : 42.06 vs. MSEGX (-11.27).
MSEGXRGACXMSEGX / RGACX
Total Expense Ratio0.820.9487%
Annual Report Gross Expense Ratio0.820.9487%
Fund Existence29 years23 years-
Gain YTD-1.735-2.54268%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets3.77B284B1%
Annual Yield % from dividends0.430.08510%
Returns for 1 year41.823.091,354%
Returns for 3 years42.9632.79131%
Returns for 5 years-11.2742.06-27%
Returns for 10 years20.2758.2835%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BIAWX50.05N/A
N/A
Brown Advisory Sustainable Growth Inv
VNVNX22.15N/A
N/A
Natixis Vaughan Nelson Mid Cap N
FBTDX96.52N/A
N/A
Franklin Biotechnology Discovery C
LCFLX12.88N/A
N/A
Lord Abbett Focused Large Cap Value C
CDWEX11.44-0.02
-0.17%
American Funds Dvlpg Wld Gr&Inc 529E